• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [20046 Records] Selected Records [0 Hits] [Clear]
Year Source Title
1993     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Telemedicine in the management of neurosurgical emergencies in Paris (systematic review, primary research, expert panel, working group)
1997     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Telemedicine in the management of neurosurgical emergencies in Paris (systematic review, primary research, expert panel, working group)
1998     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Telemedicine in the management of neurosurgical emergencies in Paris (systematic review, primary research, expert panel)
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Telemetry devices to monitor cardiac patients: a review of the safety and guidelines
2007     Institute of Health Economics (IHE) Teleoncology: applications and associated benefits for the adult population
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Telepathology: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2008     HAYES, Inc. Telephone intervention for depression
2008     HAYES, Inc. Telephone monitoring for depression
1998     Alberta Heritage Foundation for Medical Research (AHFMR) Telephone nurse triage services
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Telephone triage services: systematic review and a survey of Canadian call centre programs
2009     HAYES, Inc. Teleradiology for neurosurgical consultations
2011     HAYES, Inc. Telerehabilitation after stroke
2012     HAYES, Inc. Telerehabilitation for musculoskeletal conditions, neuromuscular conditions, and mobility impairment
1997     Danish Institute for Health Services Research (DSI) Telescopic surgery in the abdomen. Consensus report
2012     Adelaide Health Technology Assessment (AHTA) Television marketing of unhealthy food and beverages to children in Australia: a review of published evidence from 2009
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Telithromycin
2007     NIHR Horizon Scanning Centre (NIHR HSC) Temozolomide (Temodal) for advanced metastatic melanoma: horizon scanning technology briefing
2017     Agency for Care Effectiveness (ACE) Temozolomide for the treatment of malignant glioma
2006     VA Technology Assessment Program (VATAP) Temporal artery thermometry in the post-operative setting
2018     NIHR Health Technology Assessment programme Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST
2006     HAYES, Inc. Temporomandibular joint (TMJ) reconstruction with the patient-fitted TMJ reconstruction prosthesis (TMJ Concepts)
2005     Adelaide Health Technology Assessment (AHTA) Temptouch (R): infrared thermometer device for prevention of foot ulcers in people with diabetes
2006     NIHR Horizon Scanning Centre (NIHR HSC) Temsirolimus (Torisel) for advanced or metastatic renal cell carcinoma: horizon scanning technology briefing
2008     NIHR Horizon Scanning Centre (NIHR HSC) Temsirolimus (Torisel) for mantle cell lymphoma - relapsed and/or refractory
2005     NIHR Horizon Scanning Centre (NIHR HSC) Temsirolimus for locally advanced and metastatic breast cancer - horizon scanning review
2005     NIHR Horizon Scanning Centre (NIHR HSC) Temsirolimus for metastatic renal cell carcinoma (stage IV) - horizon scanning review
2010     National Institute for Health and Clinical Excellence (NICE) Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal)
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tenecteplase: single-bolus thrombolytic therapy for acute myocardial infarction
2021     Agency for Care Effectiveness (ACE) Tenofovir alafenamide for treating chronic hepatitis B infection
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tenofovir alafenamide monotherapy for hepatitis B
2009     National Institute for Health and Clinical Excellence (NICE) Tenofovir disoproxil for the treatment of chronic hepatitis B
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tenofovir disoproxil fumarate (Viread®)
2013     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tenofovir disoproxil fumarate (Viread®)
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tenofovir disoproxil fumarate (Viread®)
2014     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tenofovir disoproxil fumarate (Viread®)
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tenofovir disoproxil fumarate (Viread®) for the treatment of hepatitis B
2007     NIHR Horizon Scanning Centre (NIHR HSC) Tenofovir disoproxil fumarate for hepatitis B: horizon scanning technology briefing
2010     NIHR Health Technology Assessment programme Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection
2000     NIHR Horizon Scanning Centre (NIHR HSC) Tension free vaginal tape for urinary incontinence - horizon scanning review
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tension-free vaginal tape (TVT) for urinary incontinence
2008     Haute Autorite de sante (HAS) Tension-free vaginal tape and women stress incontinence
2004     Medical Advisory Secretariat (MAS) Tension-free vaginal tape for stress urinary incontinence
2005     HAYES, Inc. Tension-free vaginal tape procedure for treatment of female stress urinary incontinence
2002     HAYES, Inc. Tension-free vaginal tape procedure for treatment of female stress urinary incontinence
2014     NIHR Horizon Scanning Centre (NIHR HSC) Terahertz intraoperative breast cancer probe
2011     Agency for Healthcare Research and Quality (AHRQ) Terbutaline pump for the prevention of preterm birth
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Teriflunomide (Aubagio — Genzyme Canada) indication: relapsing-remitting multiple sclerosis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Teriflunomide for relapsing multiple sclerosis (MS) - first line
2013     NIHR Health Technology Assessment programme Teriflunomide for treating relapsing forms of multiple sclerosis
2004     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Teriparatide
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Teriparatide (Forsteo®) for the treatment of osteoporosis in men at increased risk of fracture
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Teriparatide and bisphosphonates for treatment of osteoporosis in women: a clinical and economic analysis
2001     NIHR Horizon Scanning Centre (NIHR HSC) Teriparatide for osteoporosis - horizon scanning review
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Teriparatide for the treatment of osteoporosis
2001     Israel Center for Technology Assessment in Health Care (ICTAHC) Terror and medicine - the challenge
2003     Israel Center for Technology Assessment in Health Care (ICTAHC) Terror and Medicine (New book written by over 100 medical experts in Israel in the fields of medicine dealing with the preparations for and treatment of victims of terror attacks)
2013     NIHR Horizon Scanning Centre (NIHR HSC) Tertomotide for locally advanced or metastatic pancreatic cancer
2005     NIHR Horizon Scanning Centre (NIHR HSC) Tesaglitazar for type 2 diabetes and associated lipid abnormalities - horizon scanning review
2011     HAYES, Inc. testing
2014     NIHR Health Services and Delivery Research programme Testing accelerated experience-based co-design: a qualitative study of using a national archive of patient experience narrative interviews to promote rapid patient-centred service improvement
2007     Haute Autorite de sante (HAS) Testing and detection of a lupus anticoagulant
1993     Health Council of the Netherlands Gezondheidsraad (GR) Testing and prediction
2006     Agency for Healthcare Research and Quality (AHRQ) Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure
2012     Medical Services Advisory Committee (MSAC) Testing for BRAF mutation in patients with metastatic melanoma for access to (1c) vemurafenib
2018     Center for Evidence-based Practice (CEP) Testing for clostridium difficile in oncology patients
2007     Agency for Healthcare Research and Quality (AHRQ) Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).
2013     Medical Services Advisory Committee (MSAC) Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib
2007     Haute Autorite de sante (HAS) Testing for FV Leiden and FII 20210G>A mutations
2007     Haute Autorite de sante (HAS) Testing for Heparin-Induced thrombocytopenia
2012     Medical Services Advisory Committee (MSAC) Testing for HER-2 status in advanced or metastatic breast cancer (stage IIIA-IV) to access lapatinib
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Testing for HER2 positive breast cancer: a cost-effectiveness analysis
2007     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Testing for HER2 positive breast cancer. Challenge for improvement of current conditions and practice
2012     Medical Services Advisory Committee (MSAC) Testing for HER2 positivity in patients diagnosed with breast cancer to determine eligibility for treatment with trastuzumab
2012     Medical Services Advisory Committee (MSAC) Testing for HER2 status in gastric cancer for access to trastuzumab
2003     ECRI Testing for HER2/NEU status in breast cancer
2017     Adelaide Health Technology Assessment (AHTA) Testing for hereditary mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
2015     Adelaide Health Technology Assessment (AHTA) Testing for hereditary mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
2023     Ontario Health Testing for homologous recombination deficiency in patients diagnosed with ovarian cancer
2013     Medical Services Advisory Committee (MSAC) Testing for V600 status in patients with locally advanced or metastatic melanoma for access to appropriate therapies
2013     Agency for Healthcare Research and Quality (AHRQ) Testing of CYP2C19 variants and platelet reactivity for guiding antiplatelet treatment
2021     NIHR Health Technology Assessment programme Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation
2003     Finnish Office for Health Care Technology Assessment (Finohta) Testing the regional application of information technology (IT) in social welfare and health care (Satakunta Macropilot project)
2005     NIHR Health Technology Assessment programme Testing treatments on animals: relevance to humans
2014     Health Quality Ontario (HQO) Testing vitamin B12 levels in neuropathy, alopecia, dizziness, and fatigue: a rapid review
2013     HAYES, Inc. Testosterone for low sexual desire in nonsurgically postmenopausal women
2009     HAYES, Inc. Testosterone for low sexual desire in premenopausal women
2009     HAYES, Inc. Testosterone for low sexual desire in surgically postmenopausal women
2022     Center for Evidence-based Practice (CEP) Testosterone reference ranges for gender diverse individuals
2002     The Swedish Council on Health Technology Assessment (SBU) Testosterone replacement in men with age-related hormone deficiency - early assessment briefs (ALERT)
2011     Center for Evidence-based Practice (CEP) Tests for early diagnosis of sepsis
2022     Norwegian Institute of Public Health (NIPH) Tests for the detection of NTRK gene fusions in patients with locally advanced or metastatic solid tumours
2003     Health Council of the Netherlands Gezondheidsraad (GR) Tetanus prophylaxis in injuries
2006     Health Council of the Netherlands Gezondheidsraad (GR) Tetrachloroethane; Health-based recommended occupational exposure limit
2015     NIHR Horizon Scanning Centre (NIHR HSC) Texture analysis of Radiological images (TexRAD) for lung cancer assessment
2021     Institute for Clinical and Economic Review (ICER) Tezepelumab for severe asthma
2014     NIHR Horizon Scanning Centre (NIHR HSC) TH-302 in combination with doxorubicin for locally advanced or metastatic, unresectable soft tissue sarcoma – first line
1999     ECRI Thalamic stimulation for Parkinson's disease
1996     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Thalamic stimulation for tremor treatment (systematic review, primary research, expert panel)
2000     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Thalamus stimulation for the treatment of pharmacotherapy resistant tremor - primary research
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Thalidomide (Thalidomide Pharmion®) in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged GE 65 years or ineligible for high dose chemotherapy